Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
44,512,797
-
Shares change
-
+14,131,321
-
Total reported value, excl. options
-
$68,540,610
-
Value change
-
+$21,890,326
-
Put/Call ratio
-
156%
-
Number of buys
-
55
-
Number of sells
-
-25
-
Price
-
$1.54
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q1 2021
112 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q1 2021.
iBio, Inc. - Common Stock (IBIO) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44,512,797 shares
.
Largest 10 shareholders include BlackRock Inc. (15,432,756 shares), VANGUARD GROUP INC (10,561,578 shares), GEODE CAPITAL MANAGEMENT, LLC (3,350,551 shares), STATE STREET CORP (2,932,181 shares), NORTHERN TRUST CORP (2,188,245 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,495,289 shares), PRINCIPAL FINANCIAL GROUP INC (1,106,018 shares), Nuveen Asset Management, LLC (610,421 shares), JPMORGAN CHASE & CO (589,424 shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (530,192 shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.